12.2 Science Talks - Amir Saberi
12.2.1 Introduction
Peek behind the curtain and learn how science and entrepreneurial spirit can lead to tech development and innovation! Join Dr Amir Saberi LinkedIn, a Founder & CEO of biotech startup Ambryon as he talks about his Academia-to-Biotech path designing and building biomanufacturing infrastructure for accelerating cell and gene therapies.
- Thursday April 2, 2026 from 10:30am - 11:45am EST
Amir received his PhD in Cell and Developmental Biology from the University of Illinois Urbana-Champaign and did his postdoctoral work at the Johns Hopkins University School of Medicine. He then worked as a Senior and Principal Scientist at Domicell and Vita Therapeutics, transitioning to Scientific Operations at Vita before founding Ambryon. Stem Cells, CRISPR, plasmids, AAVs, gene therapy, biomanufacturing; postdoc, scientist, director, CEO; Industry, startups, biotech - Ask him anything!
12.2.2 Activity
Estimated time: 50 min
12.2.2.1 Instructions
- Read the following
- Pick an Ambryon technology blog of your choice. The blogs cover base editors, AAVs, and CRISPR for gene therapy.
- Scroll through Amir’s Google Scholar page and look through publication titles, clicking on one title/topic of interest to read a description/abstract of the paper.
- Read snapshot of Amir’s proposal with Domicell about stem cell bioreactors to support stem cell therapies.
- Post three questions you could ask in the Discussion Forum at https://help.c-moor.org/c/10
- Science – What scientific question do you have about Amir’s research and development work, ranging from basic background questions to possible next steps?
- Method – What methods would you like Amir’s insight on, whether computational, genomics, AI, gene therapy, or other exciting technologies?
- Career – What advice would you ask Amir regarding how to get started, finding a mentor, etc.?